Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Andrey L. Bakulev
44  Ergebnisse:
Personensuche X
?
1

Efficacy and safety of netakimab therapy in patients with m..:

Bakulev, Andrey L. ; Pritulo, Olga A. ; Kuntsevich, Zhanna S....
Vestnik dermatologii i venerologii.  99 (2023)  5 - p. 84-95 , 2023
Link: https://doi.org/10.25208..
 
?
2

Revisiting the question of assessment by severity and class..:

Araviiskaia, Elena R. ; Samtsov, Alexey V. ; Sokolovskiy, Evgeny V....
Vestnik dermatologii i venerologii.  98 (2023)  6 - p. 48-54 , 2023
Link: https://doi.org/10.25208..
 
?
3

About the relationship of rosacea-like dermatitis:

Bakulev, Andrey L. ; Bakuleva, Maria V.
Vestnik dermatologii i venerologii.  98 (2023)  6 - p. 101-106 , 2023
Link: https://doi.org/10.25208..
 
?
4

Efficacy and safety of treatment of moderate and severe pso..:

Bakulev, Andrey L. ; Kruglova, Larisa S.
Vestnik dermatologii i venerologii.  98 (2022)  4 - p. 23-30 , 2022
Link: https://doi.org/10.25208..
 
?
5

Resolution of the Working Meeting of Experts in "Dermatolog..:

Bakulev, Andrey L. ; Vishneva, Elena A. ; Elisyutina, Olga G....
Russian Journal of Allergy.  19 (2022)  2 - p. 259-269 , 2022
Link: https://doi.org/10.36691..
 
?
6

Practical issues in the use of emollients containing filagg..:

Araviyskaya, Elena R. ; Bakulev, Andrey L. ; Gadzhigoroeva, Aida G....
Russian Journal of Allergy.  19 (2022)  2 - p. 245-258 , 2022
Link: https://doi.org/10.36691..
 
?
7

Long-term data on the proposed adalimumab biosimilar BCD-05..:

Samtsov, Alexey V. ; Bakulev, Andrey L. ; Khairutdinov, Vladislav R....
PLOS ONE.  17 (2022)  2 - p. e0263214 , 2022
Link: https://doi.org/10.1371/..
 
?
8

Revisiting the question of cutaneous vasculitis classificat..:

Samtsov, Alexey V. ; Khairutdinov, Vladislav R. ; Sokolovskiy, Evgeny V....
Vestnik dermatologii i venerologii.  97 (2021)  4 - p. 48-59 , 2021
Link: https://doi.org/10.25208..
 
?
9

Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monocl..:

Puig, Luís ; Bakulev, Andrey L. ; Kokhan, Muza M....
Dermatology and Therapy.  11 (2021)  4 - p. 1319-1332 , 2021
Link: https://doi.org/10.1007/..
 
?
10

Efficacy and safety of netakimab, a novel anti-IL-17 monocl..:

Puig, Luis ; Bakulev, Andrey L. ; Kokhan, Muza M....
Vestnik dermatologii i venerologii.  97 (2021)  4 - p. 80-91 , 2021
Link: https://doi.org/10.25208..
 
?
11

The Actual Challenges of Biologics Treatment in Patients wi..:

Bakulev, Andrey L.
Vestnik dermatologii i venerologii.  96 (2020)  2 - p. 51-57 , 2020
Link: https://doi.org/10.25208..
 
?
12

Recommendations Russian Society of Dermatovenerologists and..:

Kubanov, Alexey A. ; Bakulev, Andrey L. ; Kokhan, Muza M....
Vestnik dermatologii i venerologii.  96 (2020)  2 - p. 9-13 , 2020
Link: https://doi.org/10.25208..
 
?
13

PSORIASIS ADJUVANT THERAPY:

Bakulev, Andrey L. ; Krachevnya, S. S ; Igonina, I. A..
Russian Journal of Skin and Venereal Diseases.  20 (2017)  6 - p. 355-359 , 2017
Link: https://doi.org/10.18821..
 
?
14

Efficacy and safety profile of 2-year netakimab treatment i..:

Bakulev, Andrey I. ; Samtsov, Alexey V. ; Sokolovskiy, Evgeny V....
Vestnik dermatologii i venerologii.  98 (2022)  2 - p. 42-52 , 2022
Link: https://doi.org/10.25208..
 
?
15

Efficacy and safety of netakimab therapy in patients with m..:

Andrey L. Bakulev ; Olga A. Pritulo ; Zhanna S. Kuntsevich...
https://vestnikdv.ru/jour/article/viewFile/14864/pdf.  , 2023
Link: https://doi.org/10.25208..
 
1-15